Biomedical Occupation or Discipline – Page 33

Rapport Neuroscience Biotech Aims for Expansion with Initial Public Offering

1 year ago talkbio0Tagged clinical-stage, expansion, IPO, mental health, nervous system disorder, Neuroscience discipline, Rapport

Rapport, neuroscience, biotech, IPO, clinical-stage, expansion, pharmaceuticals, neurological disorders, mental health

AstraZeneca Invests $1.5 Billion in Singapore for State-of-the-art Antibody-Drug Conjugate Manufacturing Facility

1 year ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, expansion, Facility (object), Generalized, innovation, Investments, Singapore

AstraZeneca, Singapore, investment, antibody-drug conjugate (ADC), manufacturing facility, end-to-end production, biotechnology, pharmaceuticals, cancer treatment, innovation, global expansion.

Revolutionizing Drug Discovery: The Evolution from Target-Selective Design to AI-Powered Polypharmacology

1 year ago talkbio0Tagged AI-enabled, Drug Discovery, Machine Learning, multi-target, Polypharmacology, Precision Medicine, Systems Biology, Target-Selective Design

Drug Discovery, Target-Selective Design, AI-Enabled Polypharmacology, Machine Learning, Systems Biology, Multi-Target Drugs, Personalized Medicine.

WHO Approval for Takeda’s Dengue Vaccine: A Breakthrough in Global Health

1 year ago talkbio0Tagged Approved, Dengue Fever, Global Health, prequalification, regulatory tracker, Takeda, Vaccines, World Health Organization

WHO, Takeda, dengue vaccine, prequalification, global health, regulatory tracker, breakthrough, approval.

Biogen and Ionis Discontinue ALS Drug Development Following Unsuccessful Early Trials

1 year ago talkbio0Tagged Amyotrophic Lateral Sclerosis, Biogen, Discontinuation (procedure), Drug Development, Early-stage, Ionis, nervous system disorder, research

Biogen, Ionis, ALS, drug development, early-stage trial, disappointing results, discontinuation, neurological disorder, treatment research.

Galapagos Expands Decentralized CAR-T Manufacturing Across the Nation with Strategic Partnership

1 year ago talkbio0Tagged Biotechnology, Cancer Therapeutic Procedure, CAR-T, decentralized, expansion, Galapagos, healthcare innovation, Immunotherapy, Manufacture, nationwide, Partnership

Galapagos, decentralized CAR-T manufacturing, partnership, nationwide expansion, cancer treatment, immunotherapy, biotechnology, healthcare innovation.

Revolutionizing Protein Design: Nabla Bio Secures $26M for AI-Driven Pharmaceutical Solutions

1 year ago talkbio0Tagged Artificial Intelligence, Biotechnology, Drug Discovery, genAI protein design, healthcare innovation, Nabla Bio, pharmaceutical partners, Protein Engineering

Nabla Bio, genAI protein design, funding, pharmaceutical partners, biotechnology, protein engineering, drug discovery, artificial intelligence, healthcare innovation.

WHO Negotiations Extended for Global Pandemic Agreement

1 year ago talkbio0Tagged deadline, Disease Outbreaks, Global Health, International, Mediation, public health medicine (field), World Health Organization

World Health Organization (WHO), pandemic accord, international agreement, global health, deadline, negotiations, public health emergency, disease outbreaks.